amantadine has been researched along with 5-(n,n-hexamethylene)amiloride in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gage, PW; Horan, CR; Premkumar, A | 1 |
| Chou, D; Eldstrom, J; Fedida, D; Jalily, PH; Kwan, DC; Miller, SC; Niikura, M; Tai, SS; Tietjen, I | 1 |
| Dregni, AJ; Hong, M; Kolocouris, A; Mandala, VS; McKay, MJ; Shcherbakov, AA | 1 |
| B Andreas, L; Becker, S; Bentzen, BH; Giller, K; Jeppesen, MG; Kledal, TN; Kolocouris, A; Mujezinovic, A; Rosenkilde, MM; Toft-Bertelsen, TL; Tzortzini, E; Xue, K | 1 |
4 other study(ies) available for amantadine and 5-(n,n-hexamethylene)amiloride
| Article | Year |
|---|---|
Dengue virus M protein C-terminal peptide (DVM-C) forms ion channels.
Topics: Amantadine; Amiloride; Antineoplastic Agents; Antiviral Agents; Dengue Virus; Ion Channels; Membranes, Artificial; Peptides; Viral Matrix Proteins | 2005 |
Mechanisms of Action of Novel Influenza A/M2 Viroporin Inhibitors Derived from Hexamethylene Amiloride.
Topics: Amantadine; Amiloride; Animals; Antiviral Agents; Cell Death; Cell Line; Guanidines; Humans; Hydrogen-Ion Concentration; Influenza A virus; Influenza A Virus, H9N2 Subtype; Ion Channel Gating; Mice; Molecular Docking Simulation; Patch-Clamp Techniques; Viral Matrix Proteins | 2016 |
Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers.
Topics: Amantadine; Amiloride; Antiviral Agents; Coronavirus Envelope Proteins; Dimyristoylphosphatidylcholine; Hydrogen-Ion Concentration; Lipid Bilayers; Magnetic Resonance Spectroscopy; Models, Molecular; Phenylalanine; Phospholipids; Protein Conformation; Protein Domains; SARS-CoV-2 | 2020 |
Amantadine has potential for the treatment of COVID-19 because it inhibits known and novel ion channels encoded by SARS-CoV-2.
Topics: Amantadine; Amiloride; Antiviral Agents; Ion Channels; Rimantadine; SARS-CoV-2; Viral Proteins | 2021 |